Filament Health Corp. (FLHLF) Stock

About Filament Health Corp.

Filament Health Corp. is a pioneering company dedicated to the discovery and extraction of natural psychedelic compounds. Its operations encompass the cultivation of psychedelic plants, genetic research, advanced extraction methodologies, and the conduct of internal clinical trials. Furthermore, the firm licenses its intellectual property and potential drug substances to pharmaceutical developers, scientific researchers, and other authorized entities. The company's principal office is located in Vancouver, Canada.

Filament Health Corp. (FLHLF) stock trades at $0.00 with a market capitalization of $26179. The stock is valued at a negative price-to-earnings (P/E) ratio of -1.89, reflecting a net loss over the last twelve months, price-to-book of 0.01, price-to-sales of 0.03. Over the past 52 weeks the stock has ranged between $0.00 and $0.02, and currently trades 100.0% below its 52-week high.

On profitability, Filament Health Corp. generates a return on equity (ROE) of -250.00% (negative, reflecting a net loss), return on capital employed of -83.59%, an operating margin of -400.00%, a net profit margin of -500.00%.

Official website: filament.health